Internal Medicine, Nephrology · Decatur, TX
NPI
1689649170
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
609 Medical Center Dr, Suite 2700
Decatur, TX, 76234
Phone (940) 627-8020
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
2,862 services
Medicare patients, 2024
576
Average age 75
Drug cost, 2024
$203K
4,051 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aamir Zuberi was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 573 times for 262 patients. In total Aamir Zuberi billed 2,862 services in 23 codes, and Medicare paid $257K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 573 | 262 | $12.26 | $7,022 |
| 99214 Office E&M - Established | Office | 422 | 209 | $86.82 | $37K |
| 90960 ESRD Related Services (not dialysis) | Office | 389 | 57 | $242.87 | $94K |
| 99232 Hospital E&M - Subsequent | Facility | 337 | 133 | $58.82 | $20K |
| 99213 Office E&M - Established | Office | 327 | 234 | $57.14 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 157 | 70 | $89.10 | $14K |
| 99223 Hospital E&M - Initial | Facility | 114 | 93 | $127.28 | $15K |
| 99222 Hospital E&M - Initial | Facility | 107 | 89 | $98.55 | $11K |
| 99203 Office E&M - New | Office | 65 | 65 | $72.27 | $4,697 |
| 99215 Office E&M - Established | Office | 55 | 27 | $137.50 | $7,562 |
| 99204 Office E&M - New | Office | 48 | 48 | $116.02 | $5,569 |
| 99231 Hospital E&M - Subsequent | Facility | 43 | 34 | $37.53 | $1,614 |
| 99212 Office E&M - Established | Office | 17 | 17 | $39.32 | $668 |
| 90961 ESRD Related Services (not dialysis) | Office | 15 | 15 | $194.10 | $2,912 |
| 99291 Critical Care E&M | Facility | 14 | 11 | $161.95 | $2,267 |
By year: 2022 $334K for 2,885 services; 2023 $295K for 2,751 services; 2024 $257K for 2,862 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aamir Zuberi prescribed most often to Medicare patients was Furosemide, with 743 prescriptions and refills. In total Aamir Zuberi wrote 4,051 Medicare prescriptions that cost $203K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 743 | 1,893 | 274 | $4,898 |
| Calcitriol Generic | 689 | 1,777 | 223 | $15K |
| Losartan Potassium Generic | 255 | 648 | 96 | $3,354 |
| Allopurinol Generic | 155 | 371 | 50 | $1,302 |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 140 | 140 | Under 11 | $49K |
| Clonidine Hcl Generic | 133 | 285 | 39 | $654 |
| Carvedilol Generic | 122 | 304 | 42 | $854 |
| Prosol Parenteral Amino Acid 20% No.1 | 122 | 122 | Under 11 | $46K |
| Lisinopril Generic | 115 | 313 | 42 | $717 |
| Spironolactone Generic | 106 | 222 | 40 | $1,349 |
| Amlodipine Besylate Generic | 101 | 293 | 35 | $710 |
| Amiloride Hcl Generic | 95 | 201 | 32 | $1,134 |
| Cefuroxime Cefuroxime Axetil | 91 | 100 | 59 | $1,231 |
| Potassium Chloride Generic | 67 | 181 | 32 | $2,265 |
| Clinisol Parenteral Amino Acid 15% No.5 | 64 | 64 | Under 11 | $9,437 |
Brand drugs: - claims; generic drugs: 3,506 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Aamir Zuberi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.